Luis Wehbe

INSTEAD: a randomised switch trial of indacaterol <i>versus</i> salmeterol/fluticasone in moderate COPD

Andrea Rossi, Thys van der Molen, Ricardo del Olmo et al. · European Respiratory Journal · 2014 · 122 citations · Full text

Pharmacy, Pharmacotherapy, Pulmonary Function Testing +16

Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial

Pablo Altman, Luis Wehbe, Juergen Dederichs et al. · BMC Pulmonary Medicine · 2018 · 69 citations · Full text

Medicine, Pharmacotherapy, Respiratory Therapy +17

Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study

Gerald J. Gleich, Florence Roufosse, Geoffrey Chupp et al. · The Journal of Allergy and Clinical Immunology In Practice · 2021 · 44 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

Teresa H. Evering, Mark J Giganti, Carlee Moser et al. · Annals of Internal Medicine · 2023 · 31 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5

Marc E. Rothenberg, Florence Roufosse, Stanislas Faguer et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 22 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13